Skip to main content
Log in

Antipyretic therapy with diclofenac sodium

Observations on effect and serious side effects in critically Ill patients

  • Original Articles
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

The antipyretic activity of diclofenac sodium, 100 mg suppository was studied retrospectively in 21 applications in seven intensive care patients. Diclofenac sodium proved to be a very potent antipyretic agent with serious side effects. Acute oliguria and protracted circulatory shock occured after administration, necessitating the administration of increasing amounts of dopamine and i.v. fluids. Possible mechanisms involved are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Donker AJM, Arisz L, Brentjens RJH, Hem GK van der, Hollemans HJG (1976) The effect of indomethacin on kidneyfunction and plasma renin activity in man. Nephron 17:228

    Google Scholar 

  2. Fejes-Toth G, Magyar A, Walter J (1977) Renal respons to vasopressin after inhibition of prostaglandin synthesis. Am J Physiol 232:416

    Google Scholar 

  3. Friedman PL, Brown EJ, Gunther S, Alexander RW, Barry WH, Mudge GH, Grossman W (1981) Coronary vasoconstrictor effect of indomethacin in patients with coronary artery disease. New Engl J Med 305:1171

    PubMed  Google Scholar 

  4. Goodman and Gilman's (1980) The pharmacological basis of therapeutics 6th edn. Macmillan Publishing Co. Inc., New York

    Google Scholar 

  5. Halim AS, Sjöqvist B, Ångáard E (1976) Inhibition of prostaglandin biosynthesis in rat brain. Acta Physiol Scand (Suppl) 440:109

    Google Scholar 

  6. Horton R, Zipser R, Fickman M (1981) Prostaglandins renal function and vascular regulation. Med Cl North Am 65(4):91

    Google Scholar 

  7. Karim SMM, Somers K, Hillier K (1971) Cardiovascular and other effects of prostaglandin E2 and F2 in man. Cardiovasc Res 5:255

    PubMed  Google Scholar 

  8. Keinanen-Kiukaaniemi A, Simila S, Kapyla H (1980) Antipyretic therapy: Evaluation of diclofenac sodium as an antipyretic agent. Clin Ther 2(6):421

    Google Scholar 

  9. Menassé R, Hedwall PR, Kreatz J, Pericin C, Riesterer L, Sallmann A, Ziel R, Jaques R (1978) Farmacological properties of diclofenac sodium and its metabolites. Scand J Rheumatol (Suppl) 22:5

    Google Scholar 

  10. Okuno T, Kondo K, Suzuki H (1981) Effect of prostaglandins E2, I2 and F3 Arachidonic acid and indomethacin on pressor responses to norepinephrine in concious rats. Prostaglandins 19(6):55

    Google Scholar 

  11. Polman HA, Huijbers WAR (1980) Toepassing van Voltaren® suppositoria (diclofenac) als antipyreticum bij kinderen met koorts ten gevolge van acute infecties. Rheuma Wereldwijd 4:11

    Google Scholar 

  12. Walshe JJ, Venuto RC (1979) Acute oliguric renal failure induced by indomethacin: possible mechanism. Ann Intern Med 91:47

    PubMed  Google Scholar 

  13. Ziel R, Krupp PJ Effect on prostaglandin synthesis and antipyretic activity of non-steroidal anti-inflammatory agents. In: Lomav P, Shonbaum E, Jacob J. Karger Basel (eds) Temperature regulation and drug action. Ed., p. 223

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zandstra, D.F., Stoutenbeek, C.P. & Alexander, J.P. Antipyretic therapy with diclofenac sodium. Intensive Care Med 9, 21–23 (1983). https://doi.org/10.1007/BF01693701

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01693701

Key words

Navigation